Citation:Lee SM, Woll PJ, Rudd R, Ferry D, O'Brien M, Middleton G, et al 2009

From Cancer Guidelines Wiki

Citation


Lee SM, Woll PJ, Rudd R, Ferry D, O'Brien M, Middleton G, et al. Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2009 Aug 5;101(15):1049-57 Abstract available at HTTP://WWW.NCBI.NLM.NIH.GOV/PUBMED/19608997.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first-line setting?Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACPcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first-line setting?
  2. What is the optimal systemic therapy and duration to be used for the treatment of limited stage small cell lung cancer?